Delivery Order SPE2DB20D3104-SPE2DB23FV8M8
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,583.90 for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through March 7, 2024. The contract is a firm-fixed-price type with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,028.23 for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $1,834.55. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. This award is part of the larger $999,999,999 IDC held by Cencora, Inc. with the DLA, which serves as the primary vehicle for the company to deliver a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,184.82 for the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 20, 2023. The contract type is Firm Fixed Price. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a delivery order valued at $16,230.80 for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 20, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $6,582.48 and a completion date of November 15, 2023. The contract is a firm fixed-price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $1,522.94 and a completion date of June 18, 2024. It is a Delivery Order with a Firm Fixed Price pricing type, covering the supply of the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $9,307.25, is a delivery order for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This award is not associated with a set-aside program and was made through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $6,488.12 and an ultimate completion date of May 22, 2024. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $22,103.24 firm fixed price delivery order is for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, with a completion date of June 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB23FV8M8Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $8,037.58 for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The award was made by the Defense Logistics Agency (DLA), a major procurement agency for the Department of Defense (DoD), and has an ultimate completion date of August 15, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD and Department of Veterans Affairs (VA) healthcare programs. This contract award is not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 8/14/23 |